Sort
40,608 grants matching “prostate cancer”
Western New York Cancer Coalition (WNYC2) Center to Reduce Disparities
$769,068Willie Underwood · Roswell Park Cancer Institute Corp · U54 · FY2012 · CA
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy
$768,857Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Growth Factor Imaging
$768,482Peter L. Choyke · Basic Sciences · Z01 · FY2007 · CA
MOLECULAR CROSS-TALK: BONE METASTATIC PROSTATE CANCER AND NOCICEPTIVE NEURONS
$768,441Wake Forest University Health Sciences · · FY2017 · Department of the Army
ROLE OF PEPC, A CIRCULAR RNA ENCODED PROTEIN, IN CASTRATION-RESISTANT PROSTATE CANCER
$768,364Regents Of The University Of Minnesota · · FY2017 · Department of the Army
MOLECULAR EPIDEMIOLOGY OF PROSTATE CARCINOGENESIS
$768,348University Of Minnesota Twin Cities · R01 · FY2001 · CA
Developing Informatics Technologies to Model Cancer Gene Regulation
$768,265Xiaole Shirley Liu · Dana-Farber Cancer Inst · U24 · FY2019 · CA
A NOVEL INHIBITOR OF RIBOSOME BIOGENESIS WITH ANTITUMOR ACTIVITY IN PRECLINICAL MODELS OF PROSTATE CANCER
$768,263University Of Melbourne · · FY2022 · Department of the Army
Preserving Erectile Function by Quantifying the Nerve-Sparing step of the Robotic Prostatectomy
$768,101Andrew Hung · University Of Southern California · R01 · FY2022 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial
$767,995Douglas J Reding · Marshfield Clinic Research Foundation · N01 · FY2009 · CA
INTERVENTION DEVELOPMENT AND MEASUREMENT
$767,660Suzanne M Miller · University Of Colorado Denver · P01 · FY2007 · CA
Complementary Adenoviral Vectors for Treatment of Cancer
$767,500Magnum Therapeutics · R44 · FY2004 · CA
Complementary Adenoviral Vectors for Treatment of Cancer
$767,500Magnum Therapeutics · R44 · FY2005 · CA
Clinical trials employing cancer vaccine combination therapies
$767,212James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$767,212James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Functional assessment of genes and common genetic risk variants in ovarian cancer
$767,203Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · U19 · FY2012 · CA
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing - Administrative Core
$767,156Cheryl L Willman · University Of New Mexico Health Scis Ctr · U2C · FY2025 · CA
SAN ANTONIO CENTER OF BIOMARKERS OF RISK FOR PROSTATE CANCER (SABOR)
$767,091Ian M Thompson · University Of Texas Hlth Science Center · M01 · FY2006 · RR
Molecular Pathology of Cancer
$766,965Michael R Emmert-Buck · Clinical Sciences · Z01 · FY2007 · CA
Defining mechanisms underlying C9orf72-associated frontotemporal dementia with C. elegans and mammalian models
$766,890Robert G Kalb · Northwestern University At Chicago · R01 · FY2022 · NS
PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER SCREENING TRIAL - SCREENING CENTER
$766,675Douglas Reding · · N01 · FY2007 · CA
Co-evolution of the Reactive Microenvironment in Prostate Cancer Progression
$766,192David R Rowley · Baylor College Of Medicine · U54 · FY2009 · CA
THE ONCOGENIC PALMITOYL-PROTEIN NETWORK IN PROSTATE CANCER
$766,184Cedars-Sinai Medical Center · · FY2010 · Department of Defense
GENE-ENVIRONMENT INTERACTION IN PROSTATE CANCER
$766,178Henry Ford Health System · R01 · FY2003 · ES
Role of Neurotrophins in the Development of the Mammalian Nervous System
$766,137Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA